Doctor profile · Federal record

Dr. Philip Dreisbach, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Rancho Mirage, CA

  • NPI 1972513919
  • Accepts Medicare
  • MIPS 82.1 / 100 · 2023
  • 61 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
34490 Bob Hope Dr.
Rancho Mirage, CA 922700000
(760) 568-3613
fax (760) 340-5189
Additional location
39800 Bob Hope Dr, Ste C
Rancho Mirage, CA 922703920

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
May 26, 2020
Year of graduation
1965 — 61 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #G19293
Medicaid
CA #00G192930

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1972513919. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
126,796
Distinct HCPCS
10
Medicare allowed
$1,975,389
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 60,000 41 $1
J0897 Injection, denosumab, 1 mg 24,000 192 $23
J9271 Injection, pembrolizumab, 1 mg 11,700 14 $53
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 7,680 33 $7
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 5,960 13 $45
J1453 Injection, fosaprepitant, 1 mg 5,700 18 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,347 45 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,295 392 $8
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 1,100 14 $0
J1626 Injection, granisetron hydrochloride, 100 mcg 1,050 18 $0

In context: peer comparison

Among 8 peers in Rancho Mirage Hematology & Oncology Physician, average services per provider: 5,587. This provider delivers 23× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,421
Transactions
110
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Pfizer INC. 9 $259.69
Daiichi Sankyo INC. 10 $251.70
AstraZeneca Pharmaceuticals Lp 9 $214.11
Janssen Biotech, INC. 11 $193.78
Novartis Pharmaceuticals Corporation 10 $185.77
Takeda Pharmaceuticals U.S.A., INC. 7 $167.08
Abbvie INC. 9 $165.98
BeiGene USA, INC. 6 $163.48
E.R. Squibb & Sons, L.L.C. 16 $154.36
Merck Sharp & Dohme LLC 5 $130.08
Celgene Corporation 4 $118.24
Astellas Pharma US INC 5 $117.35
Gilead Sciences, INC. 4 $97.71
Eisai INC. 3 $78.27
Sobi, INC 2 $74.92

By nature of payment

Food and Beverage
$3,322
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
115
Patients
0
Total drug cost
$553,454
Drug Type Claims Patients Total cost
Imbruvica (Ibrutinib) Brand 21 0 $326,334
Anastrozole Generic 19 0 $337
Eliquis (Apixaban) Brand 15 0 $12,019
Prednisone Generic 14 0 $40
Allopurinol Generic 12 0 $165
Kisqali (Ribociclib Succinate) Brand 12 0 $214,111
Amlodipine Besylate Generic 11 0 $19
Bicalutamide Generic 11 0 $430

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Philip Dreisbach's medical specialty?
Dr. Philip Dreisbach practices Hematology & Oncology Physician in Rancho Mirage, CA.
Where does Dr. Philip Dreisbach practice?
Dr. Philip Dreisbach practices at 34490 Bob Hope Dr., Rancho Mirage, CA 922700000. Office phone: 7605683613.
What is Dr. Philip Dreisbach's NPI?
Dr. Philip Dreisbach's National Provider Identifier (NPI) is 1972513919, issued by NPPES.
Does Dr. Philip Dreisbach accept Medicare assignment?
Yes. Dr. Philip Dreisbach accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip Dreisbach commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.